Surgery Partners IncSGRY
▲ PositiveCapitalrelevance
Revenue and EPS beat estimates, with EBITDA also exceeding expectations.
Impact on assets 1
Health Care
Surgery Partners IncSurgery Partners beats Q2 CY2026 sales expectations
3▲1 ▼0Impact / 5
Surgery Partners reported second-quarter CY2026 revenue of $848.9 million, beating Wall Street estimates of $830.7 million and growing 2.7% year on year. Adjusted earnings per share of $0.10 surpassed analyst consensus of $0.07 by 49.4%, while adjusted EBITDA of $125.2 million also exceeded expectations. The company reaffirmed its full-year revenue guidance of approximately $3.4 billion and EBITDA guidance of $530 million at the midpoint, both in line with analyst estimates. CEO Eric Evans highlighted disciplined execution and the pending Idaho Falls transaction as part of portfolio optimization.
Surgery Partners IncRevenue and EPS beat estimates, with EBITDA also exceeding expectations.